Market News & Trends
Samsung Biologics Completes Acquisition of GSK’s Manufacturing Facility
Samsung Biologics recently announced the completion of its acquisition of a manufacturing facility in Rockville, Maryland from GSK, establishing the company’s first manufacturing presence in…
PRISM ALS: New Stem Cell Models Could Transform Research Into Treatments for MND/ALS
A new global initiative launched today aims to close a critical gap in ALS/MND drug discovery – current cell models used for testing treatments do…
Symeres & Ambagon Therapeutics Collaborate on Molecular Glue Research in Colorectal Cancer
Symeres has recently partnered with Ambagon Therapeutics, a pre-clinical biotechnology company, to explore a new class of small molecules, known as molecular glues, for potential…
ImmuneOncia Therapeutics & Lonza Collaborate to Manufacture a PD-L1 Antibody Targeting Immuno-Oncology
ImmuneOncia Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on immuno-oncology, and Lonza, one of the world’s largest contract development and manufacturing organizations (CDMOs), announced today…
Vetter Recognized as 2026 CDMO Leadership Awards Winner
Vetter receives recognition as CDMO of the year in the category “Finished Dose” of the 2026 CDMO Leadership Awards. The award honors the company for…
Thermo Fisher Scientific & SHL Medical Collaborate to Deliver Fully Integrated Drug-Device Solutions
Thermo Fisher Scientific Inc. recently announced a strategic collaboration with SHL Medical, a leading provider of advanced drug delivery systems, alongside an expansion of sterile…
Optibrium Introduces Graphical Interface for QuanSA to Enhance Ligand-Based Affinity Predictions
Optibrium recently announced a new QuanSA plugin for PyMOL, providing an intuitive Graphical User Interface (GUI) for its ligand-based binding affinity prediction method, part of…
Quotient Therapeutics Announces Collaboration With Merck to Discover Novel Drug Targets in Inflammatory Bowel Disease Using Somatic Genomics Platform Technology
Quotient Therapeutics, a company pioneering somatic genomics to inform breakthrough medicines, today announced that it has entered a multi-year research collaboration agreement with Merck, known…
Karyopharm’s Phase 3 in Myelofibrosis Met First Co-Primary Endpoint, Demonstrating Statistically Significant Improvement in Spleen Volume Reduction
Karyopharm Therapeutics Inc. recently reported topline results from its Phase 3 SENTRY trial, a randomized, double-blind, placebo-controlled trial of 60 mg selinexor in combination with…
ImmuneBridge Announces New Partnership Focus, Investment & CEO
ImmuneBridge recently announced it will make its platform available to partners – ranging from small biotech startups to established pharmaceutical companies. Therapeutic co-development partners will…
iXCells Biotechnologies Joins International Collaboration to Evaluate Chemotherapeutic Toxicity in Human Organoids
iXCells Biotechnologies recently announced it has entered an international collaboration with Rosebud Biosciences, Kantify, and Incite to evaluate off-target chemotherapeutic toxicities in patient-specific organoids. Building…
Perceptive eClinical & Kayentis Partner to Tackle Increasing Digital System Complexity in Global Clinical Trials
Perceptive eClinical and Kayentis recently announced a strategic alliance to deliver a fully integrated best-of-breed eCOA–IRT solution for clinical trials, one that offers sponsors and…
Nanexa Demonstrates Feasibility of Quarterly Semaglutide Dosing with PharmaShell
Nanexa AB recently announced highly promising new results from its long‑acting semaglutide program, developed using the company’s proprietary PharmaShell drug delivery platform. Building on the…
Clariant Expands Pharmaceutical-Grade PEG Manufacturing Into North America With Texas facility
Clariant is expanding its Clear Lake site to include excipient GMP-compliant manufacturing of pharmaceutical-grade polyethylene glycol (PEG) excipients, significantly improving their availability and reliability for…
Basecamp Research Launches Trillion Gene Atlas to Scale AI-Designed Therapeutics
Basecamp Research recently announced the launch of the Trillion Gene Atlas, a landmark scientific initiative to generate and model biological data at the trillion-gene scale.…
One-carbon Therapeutics Signs Strategic Collaboration With Tempus to Advance Molecular Insights & Enable Precision Oncology Development of TH9619
One-carbon Therapeutics recently announced a strategic collaboration with Tempus AI Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine.…
Green Light for First-in-Human Trial of KMCAR T-cell Therapy in Multiple Myeloma
HaemaLogiX Ltd and Peter MacCallum Cancer Centre (Peter Mac) are delighted to announce the achievement of a landmark regulatory milestone: receipt of Clinical Trial Approval…
Vetter Des Plaines Facility is the German American Chamber of Commerce’s Investment of the Year
The German American Chamber of Commerce awarded Vetter, a globally operating pharmaceutical service provider, the Investment of the Year Award 2026. The award was officially…
Neuland to Open Commercial Peptide Facility as part of Planned Phased Expansion
Neuland Laboratories will open its new commercial peptide facility in the summer of 2026 at its 17-acre Bonthapally manufacturing campus, with further capacity expansions planned…
Lonza & Genetix Biotherapeutics Extend Commercial Manufacturing Agreement for ZYNTEGLO
-Extended agreement will expand manufacturing capacity at Lonza Houston (US) to support growing demand for Genetix’s ZYNTEGLO (betibeglogene autotemcel), the only FDA-approved gene therapy for…
